FDA APPROVAL PENDING
Metabolic
AICAR
Performance
0
Amino acids
Molecular weight
Peptide
Type
AICAR is a cell-permeable nucleoside analog that activates AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis. Originally studied for cardiac ischemia protection, it gained attention as an 'exercise mimetic' due to its metabolic effects.
Once inside cells, AICAR is phosphorylated to ZMP, which mimics AMP and activates AMPK. This triggers metabolic pathways typically activated during exercise: increased glucose uptake, fatty acid oxidation, and mitochondrial biogenesis.
Lyophilized: -20°C; Reconstituted: 2-8°C for 4 weeks
Once daily
1-5mg daily
8-12 weeks
No visual available
Due to this peptide having no amino acids, there is no molecular chain to display.
AMPK pathway activation
Enhanced fatty acid oxidation
Improved glucose uptake
Potential endurance enhancement
Mitochondrial biogenesis stimulation
This peptide is still gaining traction in the community.
5-Aminoimidazole-4-carboxamide Ribonucleotide | AMPK Activator
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of AICAR.
Subcutaneous injection once daily. Progressive dosing protocols are common to assess tolerance.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Advanced Protocol | 3 | 8 week range | SubQ |
| Standard Protocol | 1 | 1 week range | SubQ |
| Gradual Introduction | 1 | 4 week range | SubQ |
Materials needed:
Steps to reconstitute
The AICAR Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
AICAR
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg AICAR vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Diabetes (risk of hypoglycemia)
Cardiac conditions
Pregnancy or breastfeeding
Competitive athletes (WADA prohibited)
Severe hypoglycemia symptoms
Lactic acidosis symptoms (muscle pain, weakness, difficulty breathing)
Unusual cardiac symptoms
Severe fatigue or weakness
2.0
2 reviews
5
4
3
2
1
Some Guy
Insufficient duration
Minimal effect
Unclear if it helped
Short trial
Inconsistent results
Little to no change
Honestly I've never used this peptide before!
austin
test test test
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
AICAR is a limited compound
AICAR
AICAR is a limited compound
AMPK and Exercise: Glucose Uptake and Insulin Sensitivity
Review of AMPK role in exercise-induced metabolic adaptations and AICAR as pharmacological activator.
2012
AICAR Mouse Endurance Study
Mice treated with AICAR showed 44% increase in running endurance without training.
2008